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Phylogenic analysis of human bocavirus 
detected in children with acute respiratory 
infection in Yaounde, Cameroon
Sebastien Kenmoe1,2,3, Marie‑Astrid Vernet1, Mohamadou Njankouo‑Ripa1, Véronique Beng Penlap2, 
Astrid Vabret3 and Richard Njouom1* 
Abstract 
Objective: Human Bocavirus (HBoV) was first identified in 2005 and has been shown to be a common cause of 
respiratory infections and gastroenteritis in children. In a recent study, we found that 10.7% of children with acute 
respiratory infections (ARI) were infected by HBoV. Genetic characterization of this virus remains unknown in Central 
Africa, particularly in Cameroon Leeding us to evaluate the molecular characteristics of HBoV strains in Cameroonian 
children with ARI.
Results: Phylogenetic analysis of partial HBoV VP1/2 sequences showed a low level of nucleotide variation and the 
circulation of HBoV genotype 1 (HBoV‑1) only. Three clades were obtained, two clustering with each of the reference 
strains ST1 and ST2, and a third group consisting of only Cameroon strains. By comparing with the Swedish refer‑
ence sequences, ST1 and ST2, Cameroon sequences showed nucleotide and amino acid similarities of respectively 
97.36–100% and 98.35–100%. These results could help improve strategies for monitoring and control of respiratory 
infections in Cameroon.
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Introduction
During the past two decades, new molecular techniques 
have contributed to the discovery of many viruses. This 
was the case in September 2005 with the discovery of the 
Human Bocavirus (HBoV) by a Swedish research team 
[1]. HBoV was subsequently named HBoV-1. Since, three 
other species (HBoV-2, 3, and 4) have been described 
from stool samples in Pakistan, Australia, and Nigeria 
respectively [2–4]. Based on phylogenetic analysis of 
HBoV genomic sequences, it was assigned to the Par-
voviridae family, Parvovirinae sub-family, and Bocavi-
rus genus. Indeed, the sequences identified were closely 
related to two other bocaviruses: the Bovine Parvovirus 
and the canine Minute Virus. Although this classifica-
tion was based on genetic characterization, microscopy 
studies have observed viral particles having the char-
acteristics of this family of viruses; small DNA viruses 
with unenveloped icosahedral capsid and a diameter 
ranging from 18 to 26 nm. The HBoV genome is a 5.2 kb 
linear negative sense single-stranded DNA. During the 
8th ICTV report it was decided that the different spe-
cies of the genus Bocavirus should show a similarity in 
the NS1 gene of at least 95%. Based on the analysis of a 
large number of VP1 gene sequences and calculations 
of the genetic distance of complete genomes of differ-
ent species of HBoV, Kapoor and collaborators recently 
proposed a new classification mode for HBoV suggest-
ing that HBoV strains with more than 8 and 10% differ-
ence respectively in protein and nucleotide sequences 
of the VP1 complete gene should be considered as dif-
ferent species. Those with more than respectively 1.5 
and 5% difference should be considered as different 
genotypes [3]. This proposal is consistent with the cur-
rent nomenclature of the four HBoV species. A decade 
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after the identification of HBoV-1 in Sweden, it has been 
detected at frequencies ranging from 2 to 19% [5] in sev-
eral countries across Europe [6–9], Asia [10–13], Amer-
ica [14–17], Africa [18–21], Middle East [22–24], and 
Australia [4, 25], revealing an overall distribution of this 
virus. These studies indicate that HBoV-1 is primarily 
a respiratory pathogen. HBoVs are detected not only in 
the respiratory tract (HBoV-1 and 2), but also in the gas-
trointestinal tract (HBoV-1 to 4) where they are associ-
ated with gastroenteritis [5]. HBoV are highly conserved 
viruses and sequences obtained in various regions of the 
world by several groups highlight a high homology of 
genetic sequences [7, 9, 11, 18, 22].
In a recent study, we have found that 10.7% of children 
with acute respiratory infections (ARI) were infected by a 
HBoV [21]. However, most molecular epidemiology stud-
ies of HBoVs have been performed in developed coun-
tries [5]. Genetic characterization of this virus remains 
unknown in most African countries, particularly in Cam-
eroon. This study is, to our knowledge, the first analysis of 
the genetic characteristics of HBoVs obtained from Cam-
eroonian children with acute respiratory infections (ARI).
Methods
Study population and samples
The study population was hospitalized and outpatient 
children with ARI consulting at the pediatric service 
of ‘Centre Hospitalier d’Essos’ in Yaounde, Cameroon. 
Demographic and clinical characteristics of these chil-
dren have been previously described [21]. For this study 
nasopharyngeal swab samples were used.
Laboratory analysis
DNA was extracted using QIAamp DNA Mini kit (Qia-
gen, Hiden, Germany, Cat No. 51306) from nasopharyn-
geal swab specimens following the manufacturer’s 
instructions. A final elution volume of 200  µL of DNA 
was stored a −80  °C prior to testing by a commercially 
available duplex real time PCR for the detection of human 
Adenovirus and HBoV (Respiratory Multi Well System 
r-gene™, BioMerieux, Lyon, France, Cat No. 1092480) 
following the manufacturer’s instructions. HBoV posi-
tive samples were then selected and a fragment of the 
VP1/2 capsid gene was amplified by semi-nested PCR as 
described elsewhere [18]. Briefly, 10 µL of the DNA was 
added to 50 µL of PCR mixture containing of 24.5 µL of 
water, 1.5 µL of  MgCl2 at 50 mM, 1 µL dNTPs at 10 mM, 
2,5 µL of VP-A sense primer (5′-GCACTTCTGTATCA-
GATGCCTT-3′) at 10 µM, 2.5 µL of VP-B reverse primer 
(5′-CGTGGTATGTAGGCGTGTAG-3′) at 10  µM, 5  µL 
of 10× PCR buffer, 2.5 µL of the W1 solution at 1%, and 
0.5  µL of the Taq DNA Polymerase (Invitrogen, USA, 
Cat No. 10342053). To improve the sensitivity, a second 
semi-nested reaction with 2 µL of the first PCR product 
was performed with the pair of primer VB-B and VP-C 
(5′-CTTAGAACTGGTGAGAGCACTG-3′) according to 
the previous protocol. The cycling parameters for the two 
PCR included an enzyme activation and initial denatura-
tion at 94 °C (3 min); 40 cycles of denaturation at 94 °C 
(45 s), primer annealing at 50 °C (30 s) and extension at 
72  °C (1  min 30  s); a final extension at 72  °C (10  min), 
and a hold at 4 °C. The amplified VP1/2 capsid of 980 bp 
product was observed after electrophoresis in a 1.5% aga-
rose gel.
The VP1/2 capsid PCR products were purified and 
sequenced using Big Dye Terminator cycle sequenc-
ing (Applied Biosystems, Foster City, USA, Cat No. 
4,337,454) and semi-nested PCR primers according 
manufacturer instructions. Electrophoresis and data col-
lection were done on an Applied Biosystems AB3100 
genetic analyzer. Sequences were first aligned and edited 
using Sequence Navigator1 software (Applied Biosys-
tems, Foster City, CA). The consensus sequence was gen-
erated by removing low quality base peaks at the end of 
the chromatogram and correcting base pair mismatches.
Phylogenetic analysis
Genotypes were determined by phylogenetic analysis 
comparing the consensus sequence of each sample to ref-
erence VP1/2 capsid sequences including the Swedish ref-
erence sequences ST1 and ST2, and reference sequences 
of HBoV-2 (NC_012042), HBoV-3 (NC_012564), 
HBoV-4 (NC_012729), BPV (NC_001540.1), and MVC 
(NC_004442.1).
Phylogenetic analyses were performed using MEGA 
software version 6 [26]. Briefly, sequences in FASTA for-
mat were aligned using Clustal W algorithm. Genetic 
distances were measured with the Kimura-2 parameter 
model. A phylogenetic tree was constructed with the 
neighbor-joining algorithm and robustness of the tree 
was evaluated with 1000 bootstrap resamplings.
The MEGA software version 6 was used to generate 
predicted amino acid sequences from consensus nucleo-
tide sequences by translation. The comparison of the sites 
and proportion of similarities at amino acid and nucle-
otide levels was made between consensus amino acid 
and nucleotide sequences of each Cameroonian HBoV 
sequences and ST1 and ST2 reference sequences.
All consensus nucleotide sequences obtained in this 
study were submitted to GenBank Database under acces-
sion numbers KX121135 to KX121163.
Results
Genotyping of HBoV isolates
Among the 80 HBoV positive samples, DNA in the VP1/2 
capsid region could be amplified, sequenced and analysed 
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Fig. 1 Neighbor‑joining phylogenetic tree of the 29 human bocavirus strains from Cameroon, partial VP1/2 gene (839 bp). Sequences from this 
study are in bold. The number next to the node are bootstrap values. Only bootstrap values higher than 80% are presented. ST1 are sequences 
clustering with the reference sequence ST1. ST2 are sequences clustering with the reference sequence ST2. CAM are the Cameroon cluster group
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phylogenetically in 29 samples (36.2%). The estimated 
phylogeny of these sequences and previously published 
VP1/2 capsid sequences including those of the four spe-
cies of HBoV is shown in Fig. 1. All of the 29 sequences 
clustered with HBoV-1 reference sequences. Three clades 
were obtained, two clustering with each of the reference 
strains ST1 and ST2, and a third group consisting of only 
Cameroon strains (CAM).
By comparing with the Swedish reference sequences 
ST1 and ST2, Cameroon sequences showed nucleotide 
and amino acid similarities of respectively 97.36–100% 
and 98.35–100%.
Nucleotide and aminoacid polymorphisms
Based on the VP1/2 capsid gene of the Swedish reference 
strain (accession number NC_007455), 28 of 717 nucle-
otides analyzed (position 1141–1857 of VP1/2 capsid 
gene) were found to be variable, with 21 (75%) transitions 
and 7 (25%) transversions. Ten nucleotide substitutions 
(G1243A, C1429T, G1470A, A1539G, C1542T, A1551G, 
T1619A, A1636C, T1800C, and A1821G) were specific to 
the Cameroonian clade: CAM (data not shown and avail-
able upon request). The description of the amino acid 
sequences deduced from HBoV-1 strains of this study 
was made with reference to the VP1/2 capsid domain of 
HBoV reference (accession number NC_007455), which 
extended over a length of 239 amino acids (position 381–
619). The HBoV strains analyzed in the study had the 
amino acid substitutions: G415S, N474S, F540Y, N546H, 
and S590T (data not shown and available upon request). 
Three of these amino-acid substitutions (G415S, F540Y, 
and N546H) were specific to the CAM clade.
Discussion
This study reports for the first time molecular charac-
teristics of HBoV in children suffering from acute res-
piratory infections in Cameroon. Only 29 (36.2%) tested 
samples were amplified by genotyping PCR on the VP1/2 
capsid gene during this study. This low amplification rate 
can be explained by the high sensitivity of the detection 
technique compared to the genotyping technique, and 
also by the low viral load in unamplified samples (mean 
cycle threshold unamplified samples  =  35.6  ±  1.8 vs. 
28.1  ±  6.3 for the positive, p  <  0.001). Several studies 
have shown that HBoV-1 is a respiratory pathogen [5]. As 
expected, phylogenetic analysis of partial VP1/2 capsid 
gene sequences obtained in this study also revealed the 
presence of the HBoV-1 species. These viruses circulating 
among children with acute respiratory infections in Cam-
eroon were divided into two genetic clades closely linked 
to ST1 and ST2 and a third clade made only of Cameroo-
nian strains. The sequences revealed an extremely high 
homology with the original sequences (ST1 and ST2) 
identified in Sweden in 2005. These results are consistent 
with findings of other authors from around the world [6, 
7, 23]. However, unlike these results and others [6, 7, 15–
17, 23], over 10 nucleotide substitutions leading to three 
amino acid mutations were specific to the CAM clade, 
suggesting that HBoV undergo higher selective pressures 
in Yaounde, Cameroon than in other regions.
Our study included limited number of patients from 
a single health care facility and is therefore not repre-
sentative of our country. However, our sequences are also 
similar to those circulating in other countries, highlight-
ing the low genetic variability of HBoV. In summary, our 
data indicates that HBoV-1 strains collected from 2011 to 
2014 in Yaounde are divided in three groups. Two groups 
clustered with previously reported ST1 and ST2 geno-
types, and the third group is an original Cameroonian 
genotype. The partial HBoV-1 VP1/2 gene sequences in 
Cameroon have relatively high genetic variations com-
pared to others studies.
Limitations
Our study included limited number of patients from a 
single health care facility and is therefore not representa-
tive of our country.
Authors’ contributions
RN, AV and VBP designed the study. SK, M‑AV and MN‑R carried out and inter‑
preted experiments. SK conducted phylogenetic analyses and wrote the first 
draft of the paper. All authors read and approved the final manuscript.
Author details
1 Virology Unit, Centre Pasteur of Cameroon, Yaounde, BP 1274 Yaounde, 
Cameroon. 2 Biochemistry Department, Université of Yaounde 1, Yaounde, 
Cameroon. 3 Virology Service, Pôle de Biologie, CHU de Caen, Caen, France. 
Acknowledgements
We thank all laboratory and hospital staff involved data and respiratory 
samples collection used for this study and Dr. Matthieu Schoenhals for his 
assistance with the English language.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
All HBoV sequences analyzed in this study where published on Genbank with 
accession number KX121135 to KX121163.
Ethics approval and consent to participate
Written informed consent was obtained from parents or guardians of all 
children enrolled in the study. The procedures of the original study (IMMI 
project) have been evaluated and approved by the National Research Ethics 
Committee and the Ministry of Health of Cameroon.
Funding
This work was supported by the U.S. Department of Health and Human 
Services (DHHS) Grant Number 6 DESP060001‑01‑01 via the International 
Network of Pasteur Institutes and the ‘Institut de Microbiologie et de Maladies 
Infectieuses’ (IMMI) in France.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
Page 5 of 5Kenmoe et al. BMC Res Notes  (2017) 10:293 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Received: 12 April 2017   Accepted: 12 July 2017
References
 1. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung‑Lindell A, Anders‑
son B. Cloning of a human parvovirus by molecular screening of respira‑
tory tract samples. Proc Natl Acad Sci USA. 2005;102:12891–6.
 2. Kapoor A, Slikas E, Simmonds P, Chieochansin T, Naeem A, Shaukat S, 
et al. A newly identified bocavirus species in human stool. J Infect Dis. 
2009;199:196–200.
 3. Kapoor A, Simmonds P, Slikas E, Li L, Bodhidatta L, Sethabutr O, et al. 
Human bocaviruses are highly diverse, dispersed, recombination prone, 
and prevalent in enteric infections. J Infect Dis. 2010;201:1633–43.
 4. Arthur JL, Higgins GD, Davidson GP, Givney RC, Ratcliff RM. A novel 
bocavirus associated with acute gastroenteritis in Australian children. 
PLoS Pathog. 2009;5:e1000391.
 5. Jartti T, Hedman K, Jartti L, Ruuskanen O, Allander T, Söderlund‑Venermo 
M. Human bocavirus—the first 5 years. Rev Med Virol. 2012;22:46–64.
 6. Pogka V, Moutousi A, Kossyvakis A, Kalliaropoulos A, Sgouras DN, Gian‑
naki M, et al. Genetic variability of human metapneumo‑and bocaviruses 
in children with respiratory tract infections. Influenza Other Respir Viruses. 
2014;8:107–15.
 7. Zappa A, Canuti M, Frati E, Pariani E, Perin S, Ruzza ML, et al. Co‑circulation 
of genetically distinct human metapneumovirus and human bocavirus 
strains in young children with respiratory tract infections in Italy. J Med 
Virol. 2011;83:156–64.
 8. Guido M, Quattrocchi M, Campa A, Zizza A, Grima P, Romano A, et al. 
Human metapneumovirus and human bocavirus associated with respira‑
tory infection in Apulian population. Virology. 2011;417:64–70.
 9. Dina J, Vabret A, Gouarin S, Petitjean J, Lecoq J, Brouard J, et al. Detection 
of human bocavirus in hospitalised children. J Paediatr Child Health. 
2009;45:149–53.
 10. Lu Q‑B, Wo Y, Wang H‑Y, Huang D‑D, Zhao J, Zhang X‑A, et al. Epidemic 
and molecular evolution of human bocavirus in hospitalized children 
with acute respiratory tract infection. Eur J Clin Microbiol Infect Dis. 
2015;34:75–81.
 11. Alam MM, Khurshid A, Shaukat S, Sharif S, Suleman RM, Angez M, et al. 
Human bocavirus in Pakistani children with gastroenteritis. J Med Virol. 
2015;87:656–63.
 12. Tran DN, Nguyen TQN, Nguyen TA, Hayakawa S, Mizuguchi M, Ushijima H. 
Human bocavirus in children with acute respiratory infections in Vietnam. 
J Med Virol. 2014;86:988–94.
 13. Ahn JG, Choi SY, Kim DS, Kim KH. Human bocavirus isolated from children 
with acute respiratory tract infections in Korea, 2010–2011. J Med Virol. 
2014;86:2011–8.
 14. Ghietto LM, Cámara A, Zhou Y, Pedranti M, Ferreyra S, Frey T, et al. High 
prevalence of human bocavirus 1 in infants with lower acute respiratory 
tract disease in Argentina, 2007–2009. Braz J Infect Dis. 2012;16:38–44.
 15. Longtin J, Bastien M, Gilca R, Leblanc E, de Serres G, Bergeron MG, et al. 
Human bocavirus infections in hospitalized children and adults. Emerg 
Infect Dis. 2008;14:217–21.
 16. Bastien N, Chui N, Robinson JL, Lee BE, Dust K, Hart L, et al. Detection of 
human bocavirus in Canadian children in a 1‑year study. J Clin Microbiol. 
2007;45:610–3.
 17. Kesebir D, Vazquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, 
et al. Human bocavirus infection in young children in the United States: 
molecular epidemiological profile and clinical characteristics of a newly 
emerging respiratory virus. J Infect Dis. 2006;194:1276–82.
 18. Misigo D, Mwaengo D, Mburu D. Molecular detection and phyloge‑
netic analysis of Kenyan human bocavirus isolates. J Infect Dev Ctries. 
2014;8:221–7.
 19. Smuts H, Workman L, Zar HJ. Role of human metapneumovirus, human 
coronavirus NL63 and human bocavirus in infants and young children 
with acute wheezing. J Med Virol. 2008;80:906–12.
 20. Smuts H, Hardie D. Human bocavirus in hospitalized children. S Afr Emerg 
Infect Dis. 2006;12:1457–8.
 21. Kenmoe S, Tchendjou P, Vernet M‑A, Moyo‑Tetang S, Mossus T, Njankouo‑
Ripa M, et al. Viral etiology of severe acute respiratory infections in hospi‑
talized children in Cameroon, 2011–2013. Influenza Other Respir Viruses. 
2016;10(5):386–93.
 22. Abdel‑Moneim AS, Kamel MM, Al‑Ghamdi AS, Al‑Malky MIR. Detection of 
bocavirus in children suffering from acute respiratory tract infections in 
Saudi Arabia. PLoS ONE. 2013;8:e55500.
 23. Nadji SA, Poos‑Ashkan L, Khalilzadeh S, Baghaie N, Shiraghaei MJ, Has‑
sanzad M, et al. Phylogenetic analysis of human bocavirus isolated from 
children with acute respiratory illnesses and gastroenteritis in Iran. Scand 
J Infect Dis. 2010;42:598–603.
 24. Hindiyeh MY, Keller N, Mandelboim M, Ram D, Rubinov J, Regev L, et al. 
High rate of human bocavirus and adenovirus coinfection in hospitalized 
Israeli children. J Clin Microbiol. 2008;46:334–7.
 25. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. 
Evidence of human coronavirus HKU1 and human bocavirus in Australian 
children. J Clin Virol. 2006;35:99–102.
 26. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular 
evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.
